Skip to content

Teleflex TFX Contingent consideration fair value adjustments

Contingent consideration fair value adjustments at other companies

Boston Scientific logo
Boston ScientificBSX
-$30M-700%
Globus Medical logo
Globus MedicalGMED
Bausch + Lomb logo
Bausch + LombBLCO

Other financials

Income statement

See full
Revenue$548.3M+32.3%
Gross profit$307.4M+20.4%
Operating income$20.2M-73.4%
Net income-$8.2M-109%
EPS (diluted)-$0.18-109%

Balance sheet

See full
Cash & equivalents$329.6M+16.8%
Total debt$2.8B+38.6%
Total equity$3.1B-24.7%
Total assets$6.8B-5.3%

Cash flow

See full
Operating cash flow$46.7M+68.3%
CapEx$18.8M-22.1%
Free cash flow$27.9M+676%

Valuation

See full
Market cap$5.62B-14.4%
Enterprise value$8.07B-2.0%
P/S2.6×-1.2×

Profitability

See full
Gross margin38.2%-3.0pp
Operating margin3%-11.8pp
Net margin-47.4%-56.2pp
FCF margin7.9%

Returns & leverage

See full
Return on equity-28.1%-31.6pp
Debt / equity0.9×+0.4×
Current ratio2.6×+0.3×

Where this comes from

Reported directly by Teleflex in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.

The official record: Teleflex’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Teleflex's contingent consideration fair value adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Teleflex's contingent consideration fair value adjustments?
Teleflex (TFX) reported contingent consideration fair value adjustments of -$2.63M in Q1 2026.
How has Teleflex's contingent consideration fair value adjustments changed year-over-year?
Teleflex's contingent consideration fair value adjustments decreased by 46.6% year-over-year, from -$1.8M to -$2.63M.
What is the long-term trend for Teleflex's contingent consideration fair value adjustments?
Over 3 years (2022 to 2025), Teleflex's contingent consideration fair value adjustments has grown at a 91.3% compound annual growth rate (CAGR), from $2.35M to $16.45M.